SecBot SecBot
DEFA14A ·Filed Apr 29, 2026

PEN

Penumbra Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001321732-26-000012
Proxy solicitation materials
Actionable Insight • Neutral

Monitor upcoming definitive proxy materials for vote items such as director elections, say-on-pay, or shareholder proposals. This DEFA14A alone does not provide a trading signal.

DirectionNeutral
Confidencelow
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$326.48
T+0 close · Apr 29, 2026 · via day close
Latest settled
−2.14%
T+60 · $319.49
Vs SPY
−5.25%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 30 $326.48entry
  2. T+1 · 7mo ago −0.35%α −0.57% · $325.33
  3. T+5 · 6mo ago −0.56%α −2.29% · $324.65
  4. T+20 · 6mo ago −2.51%α −7.73% · $318.30
  5. T+60 · 4mo ago −2.14%α −5.25% · $319.49

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Penumbra Inc filed DEFA14A (additional definitive proxy soliciting materials) on April 29, 2026. The filing contains graphical materials supplementing prior proxy disclosures; no textual financial data or voting details are available in the provided documents. This appears to be a routine supplement to proxy solicitation with no standalone material impact.

Key Facts

  • Filed DEFA14A on 2026-04-29 as additional definitive proxy materials
  • Filed by Penumbra Inc (registrant), not a dissident party
  • Document content consists of graphics/images; no financial figures or vote specifics extractable
  • No fee required; no preliminary proxy or soliciting material indicated

Financial Impact

Not quantifiable, no financial data in filing

Risk Factors

  • Inability to determine specific proxy issues due to lack of textual content

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
36% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001321732-26-000012
Document: 0001321732-26-000012-index-headers.html0001321732-26-000012
Document: 0001321732-26-000012-index.html0001321732-26-000012
Document: 0001321732-26-000012.txt0001321732-26-000012

Track record

11 reports on PEN

Performance horizon

1 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +1.63% at T+20 after the May 6, 2026 report. 1 of 4 went positive at some point.

Filters
  1. Nov 9, 20267d ago Institutional Cluster Mixed 3/10 Entry $321.46 Now $320.62 −0.26% settles Feb 8
  2. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $319.21 Now $320.62 +0.44% settles Feb 4
  3. Oct 29, 202618d ago 8-K Neutral 5/10 No price data
  4. Oct 29, 202618d ago Press Release Neutral 5/10 Entry $318.95 Now $320.62 +0.52% settles Jan 28
  5. Jul 30, 202615w ago Press Release Bearish 6/10 Entry $321.19 to $325.22 Now $320.62 +0.18% ▼ −1.25% +1.20% vs SPY
  6. May 7, 202627w ago 425 Bullish 7/10 Entry $324.65 to $323.02 Now $320.62 −1.24% ▼ −0.50% −4.34% vs SPY
  7. May 6, 202627w ago 8-K Bearish 6/10 Entry $324.65 to $323.02 Now $320.62 +1.24% ▲ +0.50% +4.34% vs SPY
  8. Apr 29, 202628w ago DEFA14A Neutral 2/10 Viewing Entry $326.48 to $319.49 Now $320.62 −1.79% ▼ −2.14% −5.25% vs SPY
  9. Apr 17, 202630w ago 425 Neutral 4/10 Entry $329.71 to $316.73 Now $320.62 −2.76% ▼ −3.94% −10.71% vs SPY
  10. Apr 1, 202632w ago DEFM14A Bullish 8/10 Entry $330.36 to $315.75 Now $320.62 −2.95% ▼ −4.42% −18.58% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Wed (10h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026